<div id="readability-page-1"><div><p>Guobang Pharma Ltd. reported earnings results for the nine months ended September 30, 2025. For the nine months, the company reported sales was CNY 4,469.88 million compared to CNY 4,418.15 million a year ago. Revenue was CNY 4,469.88 million compared to CNY 4,418.15 million a year ago.</p><p>Net income was CNY 670.24 million compared to CNY 578.88 million a year ago. Basic earnings per share from continuing operations was CNY 1.21 compared to CNY 1.04 a year ago. Diluted earnings per share from continuing operations was CNY 1.21 compared to CNY 1.04 a year ago.</p></div></div>

國邦醫藥

<p>國邦醫藥有限公司公佈了截至 2025 年 9 月 30 日的九個月財報。公司實現銷售額為 44.6988 億元人民幣，較去年同期的 44.1815 億元人民幣有所增長。淨收入從去年的 5.7888 億元人民幣上升至 6.7024 億元人民幣。持續經營業務的基本和攤薄每股收益均增加至 1.21 元人民幣，而去年為 1.04 元人民幣</p>

國邦醫藥有限公司公佈了截至2025年9月30日的九個月財務業績